APA

Gridelli C., Curcio C., Iaffaioli R. V., Brancaccio L., D'Aprile M., Gebbia V., Rossi A., Tortoriello A., Veltri E., Maione P., Barbarisi A., Gallo C., Guida C. & Perrone F. (20020419). Carboplatin + epirubicin +VP-16 + lenograstim followed by radiotherapy + carboplatin as radiosensitizer in limited small cell lung cancer. A multicenter phase II study. : Anticancer research.

Chicago

Gridelli C, Curcio C, Iaffaioli R V, Brancaccio L, D'Aprile M, Gebbia V, Rossi A, Tortoriello A, Veltri E, Maione P, Barbarisi A, Gallo C, Guida C and Perrone F. 20020419. Carboplatin + epirubicin +VP-16 + lenograstim followed by radiotherapy + carboplatin as radiosensitizer in limited small cell lung cancer. A multicenter phase II study. : Anticancer research.

Harvard

Gridelli C., Curcio C., Iaffaioli R. V., Brancaccio L., D'Aprile M., Gebbia V., Rossi A., Tortoriello A., Veltri E., Maione P., Barbarisi A., Gallo C., Guida C. and Perrone F. (20020419). Carboplatin + epirubicin +VP-16 + lenograstim followed by radiotherapy + carboplatin as radiosensitizer in limited small cell lung cancer. A multicenter phase II study. : Anticancer research.

MLA

Gridelli C, Curcio C, Iaffaioli R V, Brancaccio L, D'Aprile M, Gebbia V, Rossi A, Tortoriello A, Veltri E, Maione P, Barbarisi A, Gallo C, Guida C and Perrone F. Carboplatin + epirubicin +VP-16 + lenograstim followed by radiotherapy + carboplatin as radiosensitizer in limited small cell lung cancer. A multicenter phase II study. : Anticancer research. 20020419.